Stryker Orthopaedics and Court-appointed committees of attorneys representing Rejuvenate Modular Neck Hip Stem and ABG II Modular Neck Hip Stem plaintiffs in New Jersey Multicounty and Federal Multidistrict litigations reached an agreement to compensate additional eligible U.S. patients who had surgery to replace their Rejuvenate Modular Neck Hip Stem and ABG II Modular Neck Hip Stem, known as a revision surgery, prior to December 19, 2016. This follows an initial 2014 Settlement Program that covered patients who had a revision surgery prior to November 3, 2014. In that initial program, over 95% of eligible patients enrolled. Under this new agreement, additional patients are now eligible to participate and may apply for compensation.
Enrollment in the 2016 Settlement Program opened on January 17, 2017 and closed on March 31, 2017 (extended enrollment deadline). In order to enroll in the 2016 Settlement Program, patients must have first registered or updated their registration information (if applicable) with the Claims Processor by January 9, 2017 (see below for additional information regarding registration).
At least 95% of those patients with unresolved claims who registered with the Claims Processor must enroll in the 2016 Settlement Program and qualify to participate for Stryker to be required to issue awards under the 2016 Settlement Program. If fewer than 95% of those persons qualify, Stryker can terminate the Program on or before May 30, 2017. Stryker does not expect any award determinations to be made until after May 30, 2017, but it is expected that award determinations will begin thereafter if the 2016 Settlement Program is not terminated.